RxDoctor Payments Data

Tanika Harlis

Primary Podiatric Medicine · Port Saint Lucie, FLNPI 1801280862

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,724 of the $5,697 with a category attached, or 82.9%. 34 manufacturers reported payments, led by Stryker at 30.6% of the total. Reporting peaked in 2019 at $1,751 and has fallen 93.4% since, to $116 in 2025.

$5,697in general payments, 2019–2025

Across 160 payments — averaging $35.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Organogenesis Inc.$1K
  • Cook Medical LLC$338
  • Amgen$336
  • Kerecis Limited$180
  • Paratek Pharmaceuticals, Inc.$172
  • plus $2K from 28 others

What the payments were for

  • Speaking & faculty fees$2494%
  • Travel & lodging$72413%
  • Food & beverage$4,72483%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,697 in reported general payments places this provider in the 85th percentile of 68 primary podiatric medicine providers in Florida.

See all primary podiatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$776,341
Medicare patients
445
Services billed
3,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox16$495
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip14$402
Cephalexin13$348
Clindamycin Hcl14$169
Gabapentin18$79
Ibuprofen13$72

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Port Saint Lucie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →